MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?

Alcohol-related Liver Disease (ALD) is the primary cause of chronic liver disorders and hepatocellular carcinoma (HCC) development in developed countries and thus represents a major public health concern. Unfortunately, few therapeutic options are available for ALD and HCC, except liver transplantat...

Full description

Bibliographic Details
Main Authors: Mickaël Jouve, Rodolphe Carpentier, Sarra Kraiem, Noémie Legrand, Cyril Sobolewski
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/23/5557
_version_ 1797400402386223104
author Mickaël Jouve
Rodolphe Carpentier
Sarra Kraiem
Noémie Legrand
Cyril Sobolewski
author_facet Mickaël Jouve
Rodolphe Carpentier
Sarra Kraiem
Noémie Legrand
Cyril Sobolewski
author_sort Mickaël Jouve
collection DOAJ
description Alcohol-related Liver Disease (ALD) is the primary cause of chronic liver disorders and hepatocellular carcinoma (HCC) development in developed countries and thus represents a major public health concern. Unfortunately, few therapeutic options are available for ALD and HCC, except liver transplantation or tumor resection for HCC. Deciphering the molecular mechanisms underlying the development of these diseases is therefore of major importance to identify early biomarkers and to design efficient therapeutic options. Increasing evidence indicate that epigenetic alterations play a central role in the development of ALD and HCC. Among them, microRNA importantly contribute to the development of this disease by controlling the expression of several genes involved in hepatic metabolism, inflammation, fibrosis, and carcinogenesis at the post-transcriptional level. In this review, we discuss the current knowledge about miRNAs’ functions in the different stages of ALD and their role in the progression toward carcinogenesis. We highlight that each stage of ALD is associated with deregulated miRNAs involved in hepatic carcinogenesis, and thus represent HCC-priming miRNAs. By using in silico approaches, we have uncovered new miRNAs potentially involved in HCC. Finally, we discuss the therapeutic potential of targeting miRNAs for the treatment of these diseases.
first_indexed 2024-03-09T01:54:07Z
format Article
id doaj.art-b2778d115e424ea2ae0d32ea9a21f08c
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T01:54:07Z
publishDate 2023-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-b2778d115e424ea2ae0d32ea9a21f08c2023-12-08T15:12:32ZengMDPI AGCancers2072-66942023-11-011523555710.3390/cancers15235557MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?Mickaël Jouve0Rodolphe Carpentier1Sarra Kraiem2Noémie Legrand3Cyril Sobolewski4Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, FranceUniv. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, FranceUniv. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, FranceUniv. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, FranceUniv. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, FranceAlcohol-related Liver Disease (ALD) is the primary cause of chronic liver disorders and hepatocellular carcinoma (HCC) development in developed countries and thus represents a major public health concern. Unfortunately, few therapeutic options are available for ALD and HCC, except liver transplantation or tumor resection for HCC. Deciphering the molecular mechanisms underlying the development of these diseases is therefore of major importance to identify early biomarkers and to design efficient therapeutic options. Increasing evidence indicate that epigenetic alterations play a central role in the development of ALD and HCC. Among them, microRNA importantly contribute to the development of this disease by controlling the expression of several genes involved in hepatic metabolism, inflammation, fibrosis, and carcinogenesis at the post-transcriptional level. In this review, we discuss the current knowledge about miRNAs’ functions in the different stages of ALD and their role in the progression toward carcinogenesis. We highlight that each stage of ALD is associated with deregulated miRNAs involved in hepatic carcinogenesis, and thus represent HCC-priming miRNAs. By using in silico approaches, we have uncovered new miRNAs potentially involved in HCC. Finally, we discuss the therapeutic potential of targeting miRNAs for the treatment of these diseases.https://www.mdpi.com/2072-6694/15/23/5557microRNAsalcohol-related liver diseasehepatocellular carcinomamiRNAs-based therapeutics
spellingShingle Mickaël Jouve
Rodolphe Carpentier
Sarra Kraiem
Noémie Legrand
Cyril Sobolewski
MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
Cancers
microRNAs
alcohol-related liver disease
hepatocellular carcinoma
miRNAs-based therapeutics
title MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
title_full MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
title_fullStr MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
title_full_unstemmed MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
title_short MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?
title_sort mirnas in alcohol related liver diseases and hepatocellular carcinoma a step toward new therapeutic approaches
topic microRNAs
alcohol-related liver disease
hepatocellular carcinoma
miRNAs-based therapeutics
url https://www.mdpi.com/2072-6694/15/23/5557
work_keys_str_mv AT mickaeljouve mirnasinalcoholrelatedliverdiseasesandhepatocellularcarcinomaasteptowardnewtherapeuticapproaches
AT rodolphecarpentier mirnasinalcoholrelatedliverdiseasesandhepatocellularcarcinomaasteptowardnewtherapeuticapproaches
AT sarrakraiem mirnasinalcoholrelatedliverdiseasesandhepatocellularcarcinomaasteptowardnewtherapeuticapproaches
AT noemielegrand mirnasinalcoholrelatedliverdiseasesandhepatocellularcarcinomaasteptowardnewtherapeuticapproaches
AT cyrilsobolewski mirnasinalcoholrelatedliverdiseasesandhepatocellularcarcinomaasteptowardnewtherapeuticapproaches